PMC:4666274 / 4446-5323 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4666274","sourcedb":"PMC","sourceid":"4666274","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4666274","text":"Patient and healthy control recruitment criteria\nNine adult patients referred to the NHS Specialised Services-funded Mitochondrial Diagnostic Centre in London for investigation of CPEO and found to harbour a single, sporadically occurring, mtDNA deletion in skeletal muscle, and nine age- and gender-matched healthy controls were recruited. The mean age of the patients was 33 years (range: 19–52 years) with a mean age at symptom onset of 16 years (range: 12–32 years). Four patients with a clinical diagnosis of Kearns-Sayre syndrome (KSS) had a mean age at onset of 12 years (range: 6–17 years). The remaining patients with CPEO had a mean age of onset of 20 years (range: 14–32 years). The mean age of the controls was 33 years (range: 26–43 years).\nInstitutional Research Ethics Committee approval for the study, and accordingly individual subjects’ consent, was obtained.","divisions":[{"label":"title","span":{"begin":0,"end":48}},{"label":"p","span":{"begin":49,"end":753}}],"tracks":[]}